Sebastian Francis

Sheffield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMT.

Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMT.

Journal: Bone marrow transplantation

Published: November 16, 2025

Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population.

Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population.

Journal: British journal of haematology

Published: February 19, 2025

Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy.

Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy.

Journal: Leukemia

Published: April 24, 2024

European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transplantation.

European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transplantation.

Journal: Cytometry. Part B, Clinical cytometry

Published: January 15, 2024

Case report: Effectiveness of low-dose methotrexate monotherapy in post-essential thrombocythemia myelofibrosis.

Case report: Effectiveness of low-dose methotrexate monotherapy in post-essential thrombocythemia myelofibrosis.

Journal: Frontiers in medicine

Published: August 30, 2023

Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib.

Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib.

Journal: Blood

Published: August 25, 2023

The management of myelofibrosis: A British Society for Haematology Guideline.

The management of myelofibrosis: A British Society for Haematology Guideline.

Journal: British journal of haematology

Published: August 15, 2023

Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline.

Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline.

Journal: British journal of haematology

Published: August 15, 2023

Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis.

Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis.

Journal: Nature communications

Published: March 13, 2023

Clonal evolution in adult TCF3::HLF-positive acute lymphoblastic leukemia undergoing stem cell transplantation.

Clonal evolution in adult TCF3::HLF-positive acute lymphoblastic leukemia undergoing stem cell transplantation.

Journal: Annals of hematology

Published: July 11, 2022

CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.

CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.

Journal: Blood advances

Published: May 26, 2022

Assessing the impact of the 2017 European LeukemiaNet recommendations on FLT3 allelic ratio calculation and reporting in acute myeloid leukaemia.

Assessing the impact of the 2017 European LeukemiaNet recommendations on FLT3 allelic ratio calculation and reporting in acute myeloid leukaemia.

Journal: British journal of haematology

Published: November 18, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026